ISR Market Research

ISR Market Research, based in Cary, US, provides specialized market research solutions for the pharmaceutical industry, delivering actionable insights to biopharma developers and service providers. Founded in 2008, ISR Market Research operates as a market research firm focused on the pharmaceutical sector. The company is based in Cary, North Carolina, US. ISR has not undergone any reported changes in its business strategy or operations since its inception.

The founder's information is not available, nor does the company have any reported subsidiaries. ISR Market Research has been involved in 1 deal with the most recent deal occurring on March 9, 2026, indicating ongoing engagement in the market. ISR Market Research specializes in providing comprehensive market research solutions tailored to the pharmaceutical industry, offering both syndicated and custom research services. Their core product offerings deliver high-quality, actionable data to biopharma developers and their service providers, enabling informed decision-making across various drug development and manufacturing aspects.

By employing primary research methodologies, including surveys and interviews, ISR ensures the reliability and relevance of their findings. The company serves a diverse clientele, including drug manufacturers, clinical trial sponsors, and associated service providers primarily in North America, Europe, and Asia-Pacific regions. Their reports cover various topics, including clinical trials, technology, brand health, and customer perception, addressing key use cases for stakeholders seeking to understand market dynamics, customer needs, and competitive landscapes. ISR Market Research operates a subscription-based revenue model, complemented by customized research engagements.

Clients typically engage with ISR through annual subscriptions that provide access to a suite of syndicated reports, alongside bespoke studies tailored to specific business needs. This transaction structure facilitates direct relationships with B2B clients, ensuring dedicated support and tailored insights. The subscriptions may include varying pricing plans, reflecting the depth of the research and the frequency of updates provided. By leveraging their extensive panel of industry professionals, ISR is positioned to deliver insights critical for stakeholders in the pharmaceutical sector, enhancing their ability to navigate market challenges effectively.

In March 2026, ISR Market Research was acquired by Ramarketing PR Ltd. , a portfolio company of NorthEdge. The financial terms were not disclosed. This acquisition will allow Ramarketing PR Ltd.

to enhance its business development. Future growth plans may include the development of new research products and services, although specific details on upcoming launches have not been disclosed.